Hunan Nucien Pharmaceutical Co. Ltd. Class ASSE: 688189

"Hunan Nucien Pharmaceutical Co., Ltd."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

· Issued by Hunan Nucien Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Hunan Nucien Pharmaceutical Co. Ltd. Class A

All Hunan Nucien Pharmaceutical Co. Ltd. Class A news releases